Volume 3, Issue 4, Pages 197-203 (December 2009)

1 of 14

ABSTRACT

ABSTRACT + REFS

FULL-TEXT PDF (159 KB)

Restless Legs Syndrome Among the Elderly

Accepted 1 December 2009.

Summary

Restless legs syndrome is a sleep and movement disorder that affects 5–15% of the general population, with an increased prevalence among the elderly population. It not only affects quality of life but also increases risk of mortality among older adults. The diagnosis is based on clinical symptoms of the patient by four minimal essential criteria. Restless legs syndrome can be divided into primary or secondary causes. Examination should be performed to rule out potentially treatable illnesses, such as iron deficiency, renal failure or peripheral neuropathy, especially among elderly patients. The initial approach to restless legs syndrome should be nonpharmacologic management, such as good sleep hygiene, regular exercise, cognitive behavioral therapy and avoidance of certain aggravating drugs. An algorithm based on scientific evidence and expert opinion was developed for guidance of treatment. Combination or change of medication can be applied to resistant or difficult cases. Since elderly patients are prone to treatment-related side effects, the best strategy is to start medication cautiously and at the lowest recommended dosage.

Key Words: anticonvulsants , diagnosis , dopamine agents , opioid , treatment

No full text is available. To read the body of this article, please view the PDF online.

Article Outline

• Summary

• References

• Copyright

References

1. 1 Trenkwalder C , Högl B , Winkelmann J . Recent advances in the diagnosis, genetics and treatment of restless legs syndrome . J Neurol . 2009;256:539–553 . CrossRef

2. 2 Milligan SA , Chesson AL . Restless legs syndrome in the older adult: diagnosis and management . Drugs Aging . 2002;19:741–751 . CrossRef

3. 3 Cuellar NG , Strumpf NE , Ratcliffe SJ . Symptoms of restless legs syndrome in older adults: outcomes on sleep quality, sleepiness, fatigue, depression, and quality of life . J Am Geriatr Soc . 2007;55:1387–1392 . CrossRef

4. 4 Mallon L , Broman JE , Hetta J . Restless legs symptoms with sleepiness in relation to mortality: 20-year follow-up study of a middle-aged Swedish population . Psychiatry Clin Neurosci . 2008;62:457–463 . CrossRef

5. 5 Allen RP , Picchietti D , Hening WA , et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health . Sleep Med . 2003;4:101–119 . Abstract | Full Text | Full-Text PDF (238 KB) | CrossRef

6. 6 Ferri R , Lanuzza B , Cosentino FI , et al. A single question for the rapid screening of restless legs syndrome in the neurological clinical practice . Eur J Neurol . 2007;14:1016–1021 . CrossRef

7. 7 Hening WA , Allen RP , Washburn M , et al. The four diagnostic criteria for Restless Legs Syndrome are unable to exclude confounding conditions (“mimics”) . Sleep Med . 2009;10:976–981 . Abstract | Full Text | Full-Text PDF (151 KB) | CrossRef

8. 8 Allen RP , Walters AS , Montplaisir J , et al. Restless legs syndrome prevalence and impact: REST general population study . Arch Intern Med . 2005;165:1286–1292 . MEDLINE | CrossRef

9. 9 Tsuboi Y , Imamura A , Sugimura M , et al. Prevalence of restless legs syndrome in a Japanese elderly population . Parkinsonism Relat Disord . 2009;15:598–601 . Abstract | Full Text | Full-Text PDF (147 KB) | CrossRef

10. 10 Whittom S , Dauvilliers Y , Pennestri MH , et al. Ageat-onset in restless legs syndrome: a clinical and polysomnographic study . Sleep Med . 2007;9:54–59 . Abstract | Full Text | Full-Text PDF (177 KB) | CrossRef

11. 11 Ondo WG . Restless legs syndrome . Neurol Clin . 2009;27:779–799 vii. . Abstract | Full Text | Full-Text PDF (170 KB) | CrossRef

12. 12 Lee JE , Shin HW , Kim KS , et al. Factors contributing to the development of restless legs syndrome in patients with Parkinson disease . Mov Disord . 2009;24:579–582 . CrossRef

13. 13 O'Keeffe ST . Secondary causes of restless legs syndrome in older people . Age Ageing . 2005;34:349–352 . MEDLINE | CrossRef

14. 14 Wang J , O'Reilly B , Venkataraman R , et al. Efficacy of oral iron in patients with restless legs syndrome and a low-normal ferritin: a randomized, double-blind, placebo-controlled study . Sleep Med . 2009;10:973–975 . Abstract | Full Text | Full-Text PDF (159 KB) | CrossRef

15. 15 Happe S , Vennemann M , Evers S , et al. Treatment wish of individuals with known and unknown restless legs syndrome in the community . J Neurol . 2008;255:1365–1371 . CrossRef

16. 16 Aukerman MM , Aukerman D , Bayard M , et al. Exercise and restless legs syndrome: a randomized controlled trial . J Am Board Fam Med . 2006;19:487–493 . MEDLINE | CrossRef

17. 17 Hornyak M , Grossmann C , Kohnen R , et al. Cognitive behavioral group therapy to improve patients scoping strategies with restless legs syndrome: a proof-of-concept trial . J Neurol Neurosurg Psychiatry . 2008;79:823–825 . CrossRef

18. 18 Lettieri CJ , Eliasson AH . Pneumatic compression devices are an effective therapy for RLS: a prospective, randomized, double-blinded, sham-controlled trial . Chest . 2009;135:74–80 . CrossRef

19. 19 Bayard M , Avonda T , Wadzinski J . Restless legs syndrome . Am Fam Physician . 2008;78:235–240 .

20. 20 Lee HB , Hening WA , Allen RP , et al. Restless legs syndrome is associated with DSM-IV major depressive disorder and panic disorder in the community . J Neuropsychiatry Clin Neurosci . 2008;20:101–105 . CrossRef

21. 21 Rottach KG , Schaner BM , Kirch MH , et al. Restless legs syndrome as side effect of second generation antidepressants . J Psychiatr Res . 2008;43:70–75 . CrossRef

22. 22 Kim SW , Shin IS , Kim JM , et al. Bupropion may improve restless legs syndrome: a report of three cases . Clin Neuropharmacol . 2005;28:298–301 . MEDLINE | CrossRef

23. 23 Silber MH , Ehrenberg BL , Allen RP , et al. An algorithm for the management of restless legs syndrome . Mayo Clin Proc . 2004;79:916–922 . MEDLINE | CrossRef

24. 24 Trenkwalder C , Hening WA , Montagna P , et al. Treatment of restless legs syndrome: an evidence-based review and implications for clinical practice . Mov Disord . 2008;23:2267–2302 . CrossRef

25. 25 Quilici S , Abrams KR , Nicolas A , et al. Meta-analysis of the efficacy and tolerability of pramipexole versus ropinirole in the treatment of restless legs syndrome . Sleep Med . 2008;9:715–726 . Abstract | Full Text | Full-Text PDF (403 KB) | CrossRef

26. 26 von Spiczak S , Whone AL , Hammers A , et al. The role of opioids in restless legs syndrome: an [11C]diprenorphine PET study . Brain . 2005;128:906–917 . CrossRef

27. 27 Walters AS , Wagner ML , Hening WA , et al. Successful treatment of the idiopathic restless legs syndrome in a randomized double-blind trial of oxycodone versus placebo . Sleep . 1993;16:327–332 . MEDLINE

28. 28 Kushida CA , Becker PM , Ellenbogen AL , et al. Randomized, double-blind, placebo-controlled study of XP13512/GSK1838262 in patients with RLS . Neurology . 2009;72:439–446 . CrossRef

29. 29 Thorp ML , Morris CD , Bagby SP . A crossover study of gabapentin in treatment of restless legs syndrome among hemodialysis patients . Am J Kidney Dis . 2001;38:104–108 . Abstract | Full-Text PDF (51 KB) | CrossRef

30. 30 Winkelmann J , Stautner A , Samtleben W , et al. Long-term course of restless legs syndrome in dialysis patients after kidney transplantation . Mov Disord . 2002;17:1072–1076 . MEDLINE | CrossRef

31. 31 García-Borreguero D , Allen RP , Benes H , et al. Augmentation as a treatment complication of restless legs syndrome: concept and management . Mov Disord . 2007;22(Suppl 18):S476–S484 . CrossRef

32. 32 Allen RP , Ritchie SY . Clinical efficacy of ropinirole for restless legs syndrome is not affected by age at symptom onset . Sleep Med . 2008;9:899–902 . Abstract | Full Text | Full-Text PDF (181 KB) | CrossRef

33. 33 Walters AS , Winkelmann J , Trenkwalder C , et al. Long-term follow-up on restless legs syndrome patients treated with opioids . Mov Disord . 2001;16:1105–1109 . MEDLINE | CrossRef

a Department of Neurology, Mackay Memorial Hospital, Taipei, Taiwan

b Mackay Medicine, Nursing and Management College, Taipei, Taiwan

Correspondence to: Dr Shih-Jung Cheng, Department of Neurology, Mackay Memorial Hospital, Main Branch, 92, Section 2, Chungshan North Road, Taipei, Taiwan

PII: S1873-9598(10)70001-6

doi:10.1016/S1873-9598(10)70001-6

1 of 14